Epstein–Barr virus (EBV) infection is implicated in the aetiology of several different lymphoid and epithelial malignancies. EBV-encoded latent genes induce B-cell transformation in vitro by ...

A new study found that part of the Epstein-Barr virus mimics a protein made in the ... was further assessed by using a common ...

A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings from a phase 2 clinical trial for a new combination therapy for an aggressive, ...

The biggest challenge was finding a large enough EBV-negative population, given the virus’s high prevalence. In 2000, he partnered with the US military and used samples from the Department of ...

Untangling the issue with the hygiene hypothesis, Ascherio noticed the connection between infectious mononucleosis ... The link between the virus and disease has opened new ways to consider ...

Sixty years after the discovery of the Epstein–Barr virus (EBV), Münz discusses new ... the authors developed a new 3D human neurovascular unit (NVU) model in vitro that allows to probe the ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...